SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,667,000 | -15.7% | 14,507 | +14.6% | 0.02% | -13.8% |
| Q3 2014 | $1,977,000 | +27.5% | 12,655 | +0.7% | 0.03% | +38.1% |
| Q2 2014 | $1,551,000 | -74.3% | 12,573 | -78.4% | 0.02% | -74.4% |
| Q1 2014 | $6,043,000 | +544.2% | 58,327 | +459.5% | 0.08% | +530.8% |
| Q4 2013 | $938,000 | – | 10,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
| HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
| 1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
| Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
| HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
| Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
| Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
| AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
| Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |